Rice Hall James & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.96M Sell
8,003
-406
-5% -$94.6K 0.11% 167
2025
Q4
$1.74M Sell
8,409
-129
-2% -$25.5K 0.1% 171
2025
Q3
$1.58M Sell
8,538
-11
-0.1% -$1.89K 0.09% 181
2025
Q2
$1.31M Sell
8,549
-100
-1% -$15.4K 0.07% 189
2025
Q1
$1.43M Sell
8,649
-9
-0.1% -$1.41K 0.08% 183
2024
Q4
$1.25M Hold
8,658
0.07% 194
2024
Q3
$1.4M Sell
8,658
-114
-1% -$18.2K 0.08% 194
2024
Q2
$1.28M Sell
8,772
-258
-3% -$38.4K 0.08% 196
2024
Q1
$1.43M Sell
9,030
-81
-0.9% -$12.9K 0.08% 193
2023
Q4
$1.43M Hold
9,111
0.08% 202
2023
Q3
$1.42M Sell
9,111
-916
-9% -$151K 0.09% 196
2023
Q2
$1.66M Sell
10,027
-91
-0.9% -$14.7K 0.09% 189
2023
Q1
$1.57M Sell
10,118
-89
-0.9% -$14.4K 0.09% 214
2022
Q4
$1.8M Sell
10,207
-895
-8% -$155K 0.1% 199
2022
Q3
$1.81M Sell
11,102
-360
-3% -$60.9K 0.11% 195
2022
Q2
$2.04M Sell
11,462
-236
-2% -$42K 0.1% 188
2022
Q1
$2.07M Sell
11,698
-16
-0.1% -$2.72K 0.08% 210
2021
Q4
$2M Sell
11,714
-75
-0.6% -$12.3K 0.07% 211
2021
Q3
$1.9M Sell
11,789
-1,350
-10% -$230K 0.07% 215
2021
Q2
$2.17M Sell
13,139
-245
-2% -$40.6K 0.08% 199
2021
Q1
$2.2M Sell
13,384
-158
-1% -$25.6K 0.07% 202
2020
Q4
$2.13M Sell
13,542
-625
-4% -$92.2K 0.08% 184
2020
Q3
$2.11M Sell
14,167
-571
-4% -$84.5K 0.09% 158
2020
Q2
$2.07M Sell
14,738
-1,807
-11% -$263K 0.09% 145
2020
Q1
$2.17M Sell
16,545
-622
-4% -$88.2K 0.12% 134
2019
Q4
$2.5M Sell
17,167
-1,006
-6% -$136K 0.08% 143
2019
Q3
$2.35M Hold
18,173
0.08% 147
2019
Q2
$2.53M Sell
18,173
-380
-2% -$52.6K 0.08% 153
2019
Q1
$2.59M Sell
18,553
-192
-1% -$25.7K 0.08% 157
2018
Q4
$2.42M Sell
18,745
-10,326
-36% -$1.44M 0.09% 147
2018
Q3
$4.02M Sell
29,071
-370
-1% -$49.2K 0.14% 127
2018
Q2
$3.57M Sell
29,441
-350
-1% -$43.7K 0.13% 130
2018
Q1
$3.82M Sell
29,791
-1,192
-4% -$161K 0.15% 116
2017
Q4
$4.33M Sell
30,983
-500
-2% -$69.6K 0.17% 112
2017
Q3
$4.09M Sell
31,483
-4,600
-13% -$610K 0.18% 106
2017
Q2
$4.77M Sell
36,083
-550
-2% -$70.2K 0.21% 99
2017
Q1
$4.56M Sell
36,633
-327
-0.9% -$39.1K 0.22% 102
2016
Q4
$4.26M Sell
36,960
-605
-2% -$69.9K 0.21% 100
2016
Q3
$4.44M Hold
37,565
0.23% 99
2016
Q2
$4.56M Sell
37,565
-175
-0.5% -$19.9K 0.26% 93
2016
Q1
$4.08M Hold
37,740
0.24% 94
2015
Q4
$3.88M Hold
37,740
0.22% 98
2015
Q3
$3.52M Hold
37,740
0.23% 99
2015
Q2
$3.68M Sell
37,740
-6,650
-15% -$666K 0.21% 107
2015
Q1
$4.47M Sell
44,390
-4,000
-8% -$407K 0.26% 99
2014
Q4
$5.06M Sell
48,390
-75
-0.2% -$7.9K 0.31% 84
2014
Q3
$5.17M Hold
48,465
0.36% 65
2014
Q2
$5.07M Sell
48,465
-3,000
-6% -$303K 0.34% 60
2014
Q1
$5.05M Hold
51,465
0.37% 62
2013
Q4
$4.71M Buy
51,465
+1,150
+2% +$106K 0.34% 59
2013
Q3
$4.36M Hold
50,315
0.42% 58
2013
Q2
$4.32M Buy
+50,315
New +$4.27M 0.43% 55

Other funds holding JNJ

Rice Hall James & Associates's JNJ Position: Q1 2026 in Review

Rice Hall James & Associates reduced its Johnson & Johnson (JNJ) stake by 4.8% in Q1 2026, selling an estimated $94.6K and leaving 8,003 shares worth $1.96M. The position accounts for 0.11% of the portfolio, ranked #167.

Rice Hall James & Associates first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.17M in Q3 2014. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Rice Hall James & Associates held 8,003 shares of Johnson & Johnson worth $1.96M as of Q1 2026.
  • Rice Hall James & Associates sold 406 Johnson & Johnson shares in Q1 2026, an estimated $94.6K.
  • Johnson & Johnson made up 0.11% of Rice Hall James & Associates's portfolio in Q1 2026, its #167 holding.
  • Rice Hall James & Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Rice Hall James & Associates's Johnson & Johnson position peaked at $5.17M in Q3 2014.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.